Ocugen

Biotech

Ocugen COVID shot will have to wait for US market after FDA hold

Ocugen revealed in the early morning hours after Thanksgiving that the FDA placed a clinical hold on its COVID-19 vaccine. 
Kyle LaHucik Nov 29, 2021 11:27am

Ocugen climbs on phase 3 COVID vaccine data

Jul 6, 2021 9:30am

Ocugen preps dry eye disease drug for phase 3

Mar 20, 2018 10:18am

Aeterna review, Allegro eye test and Ocugen orphan tag—News of Note

Aug 9, 2017 9:46am

Chutes & Ladders—BIO elects John Maraganore as new chair

Jun 22, 2017 4:08pm

Eye specialist Ocugen looks east for second-round fundraising

Jun 15, 2017 9:42am